Comparing the longer regimen and the shorter regimen for multidrug-resistant pulmonary tuberculosis patients treated under the programmatic management of drug-resistant tuberculosis
Observational study finds comparable efficacy between shorter and longer regimens in MDR-TB patients, suggesting improved adherence with shorter regimens.
Key Points
Shorter regimens for MDR-TB led to an 88% cure rate, whereas longer regimens showed an 84% cure rate.
Both treatment regimens displayed similar treatment success rates, with treatment failures at 12% in both groups.
Assessment of treatment regimens aimed to balance efficacy, duration, and adherence among MDR-TB patients.
Prospective analysis involved 50 patients at a tertiary care hospital, indicating the importance of regimen length in treatment.